[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2000002905A3 - Methods for accelerating bone and cartilage growth and repair - Google Patents

Methods for accelerating bone and cartilage growth and repair Download PDF

Info

Publication number
WO2000002905A3
WO2000002905A3 PCT/US1999/015735 US9915735W WO0002905A3 WO 2000002905 A3 WO2000002905 A3 WO 2000002905A3 US 9915735 W US9915735 W US 9915735W WO 0002905 A3 WO0002905 A3 WO 0002905A3
Authority
WO
WIPO (PCT)
Prior art keywords
cartilage
analogues
aii
repair
bone
Prior art date
Application number
PCT/US1999/015735
Other languages
French (fr)
Other versions
WO2000002905A2 (en
Inventor
Kathleen Rodgers
Gere Dizerega
Original Assignee
Univ Southern California
Kathleen Rodgers
Gere Dizerega
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California, Kathleen Rodgers, Gere Dizerega filed Critical Univ Southern California
Priority to AU49869/99A priority Critical patent/AU756785B2/en
Priority to JP2000559134A priority patent/JP3686335B2/en
Priority to DE69911609T priority patent/DE69911609T2/en
Priority to AT99933921T priority patent/ATE250423T1/en
Priority to CA002328871A priority patent/CA2328871C/en
Priority to EP99933921A priority patent/EP1094829B8/en
Publication of WO2000002905A2 publication Critical patent/WO2000002905A2/en
Publication of WO2000002905A3 publication Critical patent/WO2000002905A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/30Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1841Transforming growth factor [TGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1875Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/29Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/14Angiotensins: Related peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655Chondrocytes; Cartilage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/34Sugars
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/32Angiotensins [AT], angiotensinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The present invention provides improved methods, kits, and compositions for enhancing bone, cartilage and cartilage repair, bone and prosthesis implantation, and attachment and fixation of cartilage and cartilage to bone or other tissues, and chondrocyte proliferation comprising the administration of an effective amount of angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues, AII fragments or analogues thereof or AII AT2 type 2 receptor agonists.
PCT/US1999/015735 1998-07-13 1999-07-12 Methods for accelerating bone and cartilage growth and repair WO2000002905A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU49869/99A AU756785B2 (en) 1998-07-13 1999-07-12 Methods for accelerating bone and cartilage growth and repair
JP2000559134A JP3686335B2 (en) 1998-07-13 1999-07-12 Methods for promoting bone and cartilage growth and repair
DE69911609T DE69911609T2 (en) 1998-07-13 1999-07-12 PROCESS FOR ACCELERATING THE GROWTH AND HEALING OF BONES AND CARTILES
AT99933921T ATE250423T1 (en) 1998-07-13 1999-07-12 METHOD FOR ACCELERATING BONES AND CARTILAGE GROWTH AND HEALING
CA002328871A CA2328871C (en) 1998-07-13 1999-07-12 Methods for accelerating bone and cartilage growth and repair
EP99933921A EP1094829B8 (en) 1998-07-13 1999-07-12 Methods for accelerating bone and cartilage growth and repair

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9265398P 1998-07-13 1998-07-13
US60/092,653 1998-07-13
US13085599P 1999-04-22 1999-04-22
US60/130,855 1999-04-22

Publications (2)

Publication Number Publication Date
WO2000002905A2 WO2000002905A2 (en) 2000-01-20
WO2000002905A3 true WO2000002905A3 (en) 2000-02-24

Family

ID=26785912

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/015735 WO2000002905A2 (en) 1998-07-13 1999-07-12 Methods for accelerating bone and cartilage growth and repair

Country Status (9)

Country Link
US (1) US6258778B1 (en)
EP (1) EP1094829B8 (en)
JP (2) JP3686335B2 (en)
AT (1) ATE250423T1 (en)
AU (1) AU756785B2 (en)
CA (1) CA2328871C (en)
DE (1) DE69911609T2 (en)
ES (1) ES2207258T3 (en)
WO (1) WO2000002905A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8920842B2 (en) 1999-11-15 2014-12-30 Piramal Healthcare (Canada) Ltd. Temperature controlled and pH dependent self gelling biopolymeric aqueous solution

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335195B1 (en) * 1997-01-28 2002-01-01 Maret Corporation Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
US20040033950A1 (en) * 2000-09-26 2004-02-19 Hock Janet M. Method of increasing bone toughness and stiffness and reducing fractures
BR0007892A (en) * 1999-02-01 2001-10-30 Genetics Inst Processes and compositions for healing and repairing articular cartilage
US6730775B1 (en) 1999-03-23 2004-05-04 University Of Southern California Methods for limiting scar and adhesion formation
US6747008B1 (en) 2000-06-19 2004-06-08 University Of Southern California Methods for treating and preventing alopecia
CN1471412B8 (en) 2000-06-29 2016-06-15 生物合成技术加拿大公司 For repairing and regeneration of cartilage and the composition of other tissue and the purposes of said composition
US20060094112A1 (en) * 2001-03-07 2006-05-04 Omotunde Babalola Biological scaffold
DE60222409T2 (en) 2001-05-31 2008-09-25 Vicore Pharma Ab TRICYCLIC CONNECTIONS, USEFUL AS ANGIOTENSIN II AGONISTS
EP1467732A1 (en) * 2002-01-22 2004-10-20 Pfizer Limited 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases
EP1485116A4 (en) * 2002-02-27 2006-06-07 Univ Wake Forest ANGIOTENSIN (1-7) AND ANGIOTENSIN (1-7) AGONISTS FOR INHIBITING CANCER GROWTH
US7957401B2 (en) * 2002-07-05 2011-06-07 Geos Communications, Inc. System and method for using multiple communication protocols in memory limited processors
JP2006500978A (en) * 2002-08-20 2006-01-12 イグザクテック・インコーポレイテッド Composition for delivery and delivery of a bone growth inducer and method for producing and applying the composition
US20080194472A1 (en) * 2003-03-27 2008-08-14 Jeffrey Allen Whitsett Use of Fgf-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7488348B2 (en) 2003-05-16 2009-02-10 Musculoskeletal Transplant Foundation Cartilage allograft plug
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US8796017B2 (en) * 2003-05-21 2014-08-05 Jms Co., Ltd. Container for preparing serum and regenerative medical process using the same
US7606217B2 (en) 2003-07-02 2009-10-20 I2 Telecom International, Inc. System and method for routing telephone calls over a voice and data network
AU2004255245B2 (en) * 2003-07-09 2009-10-22 Warsaw Orthopedic, Inc. Isolation of bone marrow fraction rich in connective tissue growth components and the use thereof to promote connective tissue formation
US7399826B1 (en) 2003-10-02 2008-07-15 Ali Sadat M Peptide for promoting healing of fractures
WO2006020981A2 (en) * 2004-08-12 2006-02-23 University Of Southern California Methods for accelerating bone growth and repair
US7309589B2 (en) 2004-08-20 2007-12-18 Vironix Llc Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
EP1926459B1 (en) 2005-09-19 2015-01-07 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
CA2651827C (en) 2006-05-26 2013-11-26 Baxter International Inc. Injectable fibrin composition for bone augmentation
WO2007148334A1 (en) 2006-06-20 2007-12-27 Ben-Gurion University Of The Negev Research And Development Authority Amphiphilic peptides and hydrogel matrices thereof for bone repair
WO2008091632A2 (en) * 2007-01-22 2008-07-31 Acologix, Inc. A peptide composition and a method of promoting cartilage formation
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
MX2009011268A (en) * 2007-04-23 2009-11-02 Baxter Int Fibrin compositions containing strontium compounds.
US9457056B2 (en) 2007-12-04 2016-10-04 Ben-Gurion University Of The Negev Research And Development Authority Peptides comprising alternating hydrophobic and anionic amino acids for treatment of osteoporosis
EP2265220A1 (en) 2008-03-05 2010-12-29 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
WO2009114461A2 (en) * 2008-03-10 2009-09-17 University Of Southern California Angiotensin (1-7) dosage forms and uses thereof
EP2367556B1 (en) * 2008-11-20 2019-01-23 Cartiheal (2009) Ltd. Solid forms for tissue repair
WO2010111617A2 (en) 2009-03-27 2010-09-30 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
AT508569A1 (en) * 2009-07-23 2011-02-15 Affiris Ag PHARMACEUTICAL COMPOUND
US9677042B2 (en) 2010-10-08 2017-06-13 Terumo Bct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
EP2455388A1 (en) 2010-11-23 2012-05-23 LanthioPep B.V. Novel angiotensin type 2 (AT2) receptor agonists and uses thereof.
WO2012103347A1 (en) * 2011-01-26 2012-08-02 Whitson Stanley William Hydrogel bioscaffold and coating for bone and tooth repair
AU2012212220B2 (en) 2011-02-02 2013-04-04 University Of Southern California Methods for treating diabetic foot ulcers
ES2387057B1 (en) 2011-02-16 2013-07-19 Valeria Lucila Sainz Prestel USE OF A VEGETABLE EXTRACT AS AN ACTIVE PRINCIPLE FOR THE DEVELOPMENT OF A PRODUCT WITH PHARMACOLOGICAL ACTIVITY FOR THE TREATMENT OF TISSULAR INJURIES AND PROCEDURE OF OBTAINING THE EXTRACT
EP2849773A1 (en) 2012-05-14 2015-03-25 University of Southern California Methods for limiting development of a skin wound
US8557958B1 (en) 2012-06-18 2013-10-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of diabetes
EP2875125B1 (en) * 2012-07-20 2018-10-24 Alfred C. Kuo Methods for producing cartilage and bone
US8633158B1 (en) 2012-10-02 2014-01-21 Tarix Pharmaceuticals Ltd. Angiotensin in treating brain conditions
AU2013342257B2 (en) 2012-11-08 2018-08-30 Smith & Nephew, Inc. Improved reattachment of detached cartilage to subchondral bone
AU2013342255B2 (en) 2012-11-08 2017-05-04 Smith & Nephew, Inc. Methods and compositions suitable for improved reattachment of detached cartilage to subchondral bone
AU2014233185B2 (en) 2013-03-15 2018-03-15 University Of Southern California Methods, compounds, and compositions for the treatment of angiotensin-related diseases
EP2968441A1 (en) 2013-03-15 2016-01-20 University of Southern California Methods for treating multiple sclerosis
CN105873598A (en) 2013-07-03 2016-08-17 代表亚利桑那大学的亚利桑那校董会 Method for treating cognitive dysfunction
CN105992816B (en) 2013-11-16 2018-04-17 泰尔茂比司特公司 Cell amplification in bioreactor
US9333233B2 (en) 2014-02-25 2016-05-10 Tarix Pharmaceuticals Ltd. Methods and compositions for the delayed treatment of stroke
EP3122866B1 (en) 2014-03-25 2019-11-20 Terumo BCT, Inc. Passive replacement of media
AU2015264367A1 (en) * 2014-05-19 2016-12-15 Trevena, Inc. Synthesis of Beta-Arrestin Effectors
US9796759B2 (en) 2014-07-21 2017-10-24 Arizona Board Of Regents On Behalf Of The University Of Arizona Ang-(1-7) derivative oligopeptides and methods for using and producing the same
US10183055B2 (en) 2014-07-21 2019-01-22 Arizona Board Of Regents On Behalf Of The University Of Arizona Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
JP6830059B2 (en) 2014-09-26 2021-02-17 テルモ ビーシーティー、インコーポレーテッド Scheduled cell feeding
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US11702634B2 (en) 2017-03-31 2023-07-18 Terumo Bct, Inc. Expanding cells in a bioreactor
WO2021023698A1 (en) 2019-08-02 2021-02-11 Lanthiopep B.V Angiotensin type 2 (at2) receptor agonists for use in the treatment of cancer
US12043823B2 (en) 2021-03-23 2024-07-23 Terumo Bct, Inc. Cell capture and expansion
US12152699B2 (en) 2022-02-28 2024-11-26 Terumo Bct, Inc. Multiple-tube pinch valve assembly

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996014858A1 (en) * 1994-11-14 1996-05-23 University Of Southern California Use of angiotensin ii fragments and analogs thereof in tissue repair
WO1996039164A1 (en) * 1995-06-06 1996-12-12 The University Of Southern California Use of angiotensin ii type 2 receptor agonists in tissue repair
WO1999046285A2 (en) * 1998-03-11 1999-09-16 University Of Southern California Method of promoting production of living tissue equivalents

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68218A (en) 1983-03-23 1985-12-31 Univ Ramot Compositions for cartilage repair comprising embryonal chondrocytes
US5013649A (en) 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
IL83003A (en) 1986-07-01 1995-07-31 Genetics Inst Osteoinductive factors
US5736372A (en) 1986-11-20 1998-04-07 Massachusetts Institute Of Technology Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
US5053050A (en) 1988-04-29 1991-10-01 Samuel Itay Compositions for repair of cartilage and bone
US5162430A (en) 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US5171273A (en) 1989-01-13 1992-12-15 University Of Medicine And Dentistry Of New Jersey Synthetic collagen orthopaedic structures such as grafts, tendons and other structures
US5015629A (en) 1989-06-26 1991-05-14 University Of Southern California Tissue repair
US5686116A (en) 1990-01-12 1997-11-11 New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery Methods of enhancing repair, healing and augmentation of bone implants
DE69111021T2 (en) 1990-10-31 1996-01-04 Gendler El Flexible membrane made from organic bone matrix for repairing and restoring bones.
DE69307299T2 (en) 1992-02-14 1997-04-30 Board of Regents, the University of Texas System, Austin, Tex. MULTI-PHASE, BIODEGRADABLE IMPLANT / CARRIER AND METHOD FOR THE PRODUCTION THEREOF
US5589452A (en) 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
EP1333034B1 (en) 1993-09-24 2010-07-14 University Of Southern California Use of angiotensin II analogs in tissue repair
AU706333B2 (en) 1993-09-24 1999-06-17 University Of Southern California Use of angiotensin III and analogs thereof in tissue repair
US5443515A (en) 1994-01-26 1995-08-22 Implex Corporation Vertebral body prosthetic implant with slidably positionable stabilizing member
US5656598A (en) 1994-03-08 1997-08-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Use of fibroblast growth factors to stimulate bone growth
US5614515A (en) 1994-11-17 1997-03-25 University Of Southern California Lazaroid-based compositions and method for preventing adhesion formation using the same
AU698619B2 (en) 1995-06-07 1998-11-05 University Of Southern California Method for reducing or preventing post-surgical adhesion formation using 5-lipoxygenase inhibitors
JP3422609B2 (en) 1995-11-14 2003-06-30 花王株式会社 Disposable diapers
US5700774A (en) 1996-03-26 1997-12-23 Genetics Institute, Inc. Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
US6110895A (en) 1996-12-16 2000-08-29 University Of Southern California Method of promoting healing in skin grafts
US6335195B1 (en) 1997-01-28 2002-01-01 Maret Corporation Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
WO1998033813A2 (en) 1997-02-04 1998-08-06 University Of Southern California Method for accelerating healing of thermal injuries
AU1706399A (en) 1997-11-26 1999-06-15 University Of Southern California Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
WO1999031125A1 (en) 1997-12-12 1999-06-24 University Of Southern California Wound healing compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996014858A1 (en) * 1994-11-14 1996-05-23 University Of Southern California Use of angiotensin ii fragments and analogs thereof in tissue repair
WO1996039164A1 (en) * 1995-06-06 1996-12-12 The University Of Southern California Use of angiotensin ii type 2 receptor agonists in tissue repair
WO1999046285A2 (en) * 1998-03-11 1999-09-16 University Of Southern California Method of promoting production of living tissue equivalents

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; HAGIWARA, MITSUHIDE ET AL.: "Regulation of bone metabolism by vasoactive peptides", XP002900711, retrieved from STN FILE CA Database accession no. 129:36502 *
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; HATTON, R. ET AL.: "Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro", XP002900713, retrieved from STN accession no. 127:1149 *
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; LAMPARTER, S. ET AL.: "Effects of angiotensin II on bone cells in vitro", XP002900712, retrieved from MEDLINE accession no. 1998150748 *
J. ENDOCRINOL., vol. 152, no. 1, 1997, pages 84x5 - 10, ISSN: 0022-0795 *
JOURNAL OF CELLULAR PHYSIOLOGY, vol. 175, no. 1, April 1998 (1998-04-01), pages 89 - 98, ISSN: 0021-9541 *
SAISHIN IGAKU, vol. 53, no. 6, 1998, pages 1289 - 1294, ISSN: 0370-8241 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8920842B2 (en) 1999-11-15 2014-12-30 Piramal Healthcare (Canada) Ltd. Temperature controlled and pH dependent self gelling biopolymeric aqueous solution

Also Published As

Publication number Publication date
AU756785B2 (en) 2003-01-23
CA2328871C (en) 2002-10-01
EP1094829A2 (en) 2001-05-02
EP1094829B8 (en) 2004-09-22
DE69911609T2 (en) 2004-07-01
EP1094829B1 (en) 2003-09-24
JP2002520334A (en) 2002-07-09
JP2005120094A (en) 2005-05-12
WO2000002905A2 (en) 2000-01-20
ATE250423T1 (en) 2003-10-15
DE69911609D1 (en) 2003-10-30
CA2328871A1 (en) 2000-01-20
ES2207258T3 (en) 2004-05-16
JP3686335B2 (en) 2005-08-24
US6258778B1 (en) 2001-07-10
AU4986999A (en) 2000-02-01

Similar Documents

Publication Publication Date Title
WO2000002905A3 (en) Methods for accelerating bone and cartilage growth and repair
BR0010152A (en) Body to provide growth and growth into bone tissue and / or connective tissue and method of making that body
AU2118601A (en) Ankle replacement system
AU2154700A (en) Systems for securing sutures, grafts and soft tissue to bone and periosteum
NO2014010I2 (en)
EP1275396A3 (en) Use of angiotensin II fragments and analogs thereof in tissue repair
MXPA03011236A (en) Calcium phosphate delivery vehicles for osteoinductive proteins.
WO2000053211A3 (en) Method of promoting myocyte proliferation and myocardial tissue repair
MY141384A (en) Prevention of loss and restoration of bone mass by certain prostaglandin agonists
CA2397071A1 (en) Materials and methods for improved bone tendon bone transplantation
WO1999038543A3 (en) Bone paste subjected to irradiative and thermal treatment
WO2003013342A3 (en) Materials and methods for improved bone tendon bone transplantation
MX9803992A (en) Methods of increasing lean tissue mass using ob protein compositions.
WO2001039694A3 (en) Repair of damaged tissue
DE69931247D1 (en) RESORBABLE, DEFORMABLE BONE PLATE
ATE194275T1 (en) INTERVERTEBRACLE BODY
EP0961613A4 (en) Methods and compositions for the treatment of bone resorption disorders, including osteoporosis
WO2000035939A3 (en) Connective tissue growth factor fragments and methods and uses thereof
AU7143898A (en) Trap-coated bone grafts and prostheses
WO2001057082A3 (en) Extraction of growth factors from tissue
AP9801269A0 (en) Prostaglandin agonists.
CA2322963A1 (en) Methods to increase white blood cell survival after chemotherapy
CA2323237A1 (en) Improved radiation therapy methods
ATE543451T1 (en) BIOABSORBABLE, OSTEOGENETIC BONE PLATE
WO2000025829A3 (en) Radiodense compositions

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP MX US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP MX US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 49869/99

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: PA/a/2001/000405

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 2328871

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1999933921

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 559134

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1999933921

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1999933921

Country of ref document: EP